What Is a Biotech Catalyst?
A catalyst is a scheduled (or semi-scheduled) event that can rapidly change the probability of a drug succeeding—clinical trial readouts, FDA decisions, advisory committee votes, or regulatory updates.
Why These Names Move So Hard
- Binary outcomes: markets reprice probability quickly.
- Small caps: limited liquidity can exaggerate moves.
- Dilution risk: biotech companies often raise money around catalysts.
How to Interpret Catalyst Calendars
- Know the event type: FDA decision vs trial data vs committee vote.
- Check prior data: earlier phase results can hint at probability (never guaranteed).
- Watch financing: offerings can happen into strength.
- Plan gaps: price can open far away from your stop.
Risk Management Basics
- Size smaller: binary events don’t respect “normal” risk rules.
- Avoid all-in positions: even “sure things” can fail.
- Expect wide spreads: options liquidity can be brutal near the event.
FAQ
Can I trade catalysts without understanding biotech?
You can, but it’s closer to event-driven speculation. If you do it, keep sizing disciplined and use calendars as a warning system, not a promise of profit.